Biogen Gets First US Tocilizumab Biosimilar

FDA Approves Bio-Thera-Partnered Tofidence; Biogen Is ‘Evaluating Launch Timeline’

Tocilizumab vial in foreground
Biogen and Bio-Thera’s tocilizumab biosimilar has received FDA approval • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Biosimilars

More from Products